Filling the need for trusted information on national health issues
An interactive tool from the Kaiser Family Foundation is now updated with 2015 data, allowing users to view on a local level the share of potential enrollees who signed up for a health plan in a federally-based marketplace under the Affordable Care Act. With Mapping Marketplace Enrollment, users can also…
In his latest column for The Wall Street Journal’s Think Tank, Drew Altman discusses new Census Department survey data showing higher health spending growth over the last four economic quarters, and raises the question: is the health spending slowdown over? All previous columns by Drew Altman are available.
HIV Testing Events Scheduled at Select Walgreens Locations Over Three Days in Lead Up to National HIV Testing Day, June 27 DEERFIELD, Ill. and MENLO PARK, Calif., June 18, 2015– In the lead up to National HIV Testing Day on June 27, Walgreens and Greater Than AIDS, a leading national…
With recent news about possible health insurance company mergers, Drew Altman looks beyond the impact on Wall Street to how mergers could affect Medicare beneficiaries in his latest column for The Wall Street Journal’s Think Tank. All previous columns by Drew Altman are available.
Steep Drops in Problems Paying For and Getting Care among Recently Insured, But Affordability and Access Problems Remain Eligible Latinos Obtained Coverage at Similar Rates as Whites; People Ineligible Due to Immigration Status Now Make Up 41% of Remaining Uninsured MENLO PARK, Calif. – About two thirds (68%) of…
Large Bipartisan Majorities Support Range of Policy Changes They Believe Would Curb Drug Costs Opinion on the Affordable Care Act Remains Largely Unchanged In August About half of Americans (54%) report currently taking a prescription drug, and a large majority of them (72%) say their prescriptions are very or somewhat…
Drawing on the latest Kaiser Family Foundation comprehensive survey of New Orleans, Drew Altman discusses a growing racial divide in the city about perceptions of economic opportunity for blacks and whites and what progress and challenges in New Orleans may mean for urban America in his latest column for The Wall…
In his latest column for The Wall Street Journal’s Think Tank, Drew Altman explores the data behind public concern about prescription drug costs and highlights that the people most in need are the most burdened by the problem. All previous columns by Drew Altman are online.
In his latest column for The Wall Street Journal’s Think Tank, Drew Altman says the debate about whether to keep or repeal the Cadillac tax is more than a debate between sound policy and good politics, there are strong substantive arguments on both sides. All previous columns by Drew Altman are…
In his latest column for The Wall Street Journal’s Think Tank, Drew Altman discusses a recent success in global HIV treatment and how successes may get less attention than they deserve because of prevailing attitudes about the corruption in foreign aid. All previous columns by Drew Altman are available.
